Singapore markets open in 6 hours 55 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,034.87 -0.82 (-0.02%) Dow
37,983.77 +167.85 (+0.44%) Nasdaq
15,670.36 +12.54 (+0.08%) Bitcoin USD
57,714.64 -2,633.96 (-4.36%) CMC Crypto 200
1,194.53 -144.54 (-10.79%)
ABT May 2024 121.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:33PM EDT. Market open.
| Previous close | 10.72 |
| Open | 10.72 |
| Bid | 13.65 |
| Ask | 15.20 |
| Strike | 121.00 |
| Expiry date | 2024-05-24 |
| Day's range | 10.72 - 10.72 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.